Search results
What Makes Equifax (EFX) a Prospective Investment Bet?
Insider Monkey via Yahoo Finance· 2 hours agoMar Vista Investment Partners, LLC, an investment management company, released the “Mar Vista...
Equifax Inc.'s (NYSE:EFX) Intrinsic Value Is Potentially 66% Above Its Share Price
Simply Wall St. via Yahoo Finance· 2 days ago(NYSE:EFX) as an investment opportunity by projecting its future cash...
Equifax Inc. (NYSE:EFX) Shares Sold by Osterweis Capital Management Inc.
ETF DAILY NEWS· 2 days agoOsterweis Capital Management Inc. lowered its stake in shares of Equifax Inc. (NYSE:EFX – Free...
Equifax (NYSE:EFX) Shares Up 8.4%
ETF DAILY NEWS· 3 days agoEquifax Inc. (NYSE:EFX – Get Free Report) shares shot up 8.4% during mid-day trading on Wednesday . A number of equities research analysts have recently...
Sei Investments Co. Raises Holdings in Equifax Inc. (NYSE:EFX)
ETF DAILY NEWS· 5 days agoSei Investments Co. lifted its holdings in shares of Equifax Inc. (NYSE:EFX – Free Report) by 111.7%...
'The Boys' Season 4 features a 'Human Centipede'-inspired scene that is horrifying viewers: "I can’t...
Decider· 4 days agoThe Boys has set a high bar for sex and violence in television, yet the Amazon Prime series...
Arturia releases FX Collection 5, adding a new exciter and limiter and two EFX multi-effects
MusicRadar via Yahoo News· 6 days agoWhat's more, FX Collection 5 now features two existing Arturia effects, EFX Refract and EFX Motions....
AKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC...
Morningstar· 6 days agoNEW ORLEANS, June 11, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until ...
DocuSign (DOCU) Stock Declines 6.6% Despite Q1 Earnings Beat
Zacks via Yahoo Finance· 6 days agoOMC’s earnings of $1.67 per share beat the consensus estimate by 9.9% and increased 7.1% year over...
Akero Therapeutics, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy...
Morningstar· 6 days agoThe Portnoy Law Firm advises Akero Therapeutics, Inc. ("Akero" or the “Company”) (NASDAQ: AKRO) investors that a class action has been filed on behalf of investors. Akero investors that lost ...